Esperion Therapeutics (ESPR) - NASDAQ
  • IndyPEG | Send Message 15 Jul

    $ESPR caught a bid. Somebody wanted in real bad this morning
    Reply
      • Alexander Valtsev | Send Message 30 Jun

        Why AeroVironment, Southwestern Energy, and Esperion Therapeutics Slumped Today: http://bit.ly/2971HHJ $HHJ $SWN $AVAV $ESPR
        Reply
          • Simon Daly | Send Message 30 Jun

            Esperion Therapeutics Updates On Lack Of FDA Clarity For ETC 1002 $ESPR http://seekingalpha.com/a/2df9m
            Reply
              • EP Vantage | Send Message 30 Jun

                Esperion Winded In Chase Of A Changing Standard Of Care $ESPR http://seekingalpha.com/a/2df85
                Reply
                  • pat45 | Send Message 29 Jun

                    bot $ESPR 9.75 on drop due future test design questions. It has $9 cash and $4 investments per share and slow $2.3 burn rate so has time
                    Reply
                      • wilkinson99 | Send Message 29 Jun

                        Premarket Top % Losers: $GALE -80%, $LPCN -50%, $ESPR -32%, $ECR -13%, $UVXY -8%, $TVIX -7%, $DGAZ $LABD $SKLN $YANG $ALV $KTOV $DRIP $CYTR
                        Reply (1)
                        • Chris DeMuth Jr. | Send Message 29 Jun
                          : $GALE is reverting to making sense.
                          • Simon Daly | Send Message 10 Jun

                            Esperion Therapeutics: Why IMPROVE-IT Hasn't Cast A Shadow Over ETC-1002 $ESPR http://seekingalpha.com/a/2dc0l
                            Reply
                              • Simon Daly | Send Message 3 Jun

                                Esperion Therapeutics: What Are The Risks To ETC 1002's Efficacy? $ESPR http://seekingalpha.com/a/2daqu
                                Reply
                                  • Andrew D. Crockett | Send Message 4 Apr

                                    $CLDX daily topping tail at .33. $DSKX halted. $BUFF tanking. $ESPR could fill gap back up to 20
                                    Reply
                                      • Michael Blake Kuritz | Send Message 2 Mar

                                        $ESPR in full lift off mode. Looking to break 20.
                                        Reply
                                          Company Description
                                          Esperion Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on developing and commercializing first-in-class, oral, low-density lipoprotein cholesterol lowering therapies for the treatment of patients with hypercholesterolemia and other cardiometabolic risk markers.... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States